EATG » Tuberculosis

Tuberculosis

Japan makes significant contribution to Global Fund

TOKYO — The Global Fund to Fight AIDS, Tuberculosis and Malaria applauds Japan’s latest contribution of US$339.3 million to the Global Fund, signaling strong leadership in global health by Japan.…

UNAIDS reports mixed progress towards reaching the 2020 target of reducing TB deaths among people living with HIV by 75%

Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely.…

Drug resistant strains could become the dominant form of TB in Europe: it’s time to end TB

If the current situation continues, the majority of tuberculosis (TB) patients in the next generation could be suffering from drug resistant forms of the disease. The latest WHO/European Centre for…

It’s Time: GNP+ and TBpeople join forces to end TB and TB/HIV

The Global Network of People living with HIV (GNP+) and TBpeople recognises March 24th as World TB Day, the annual day to focus attention on tuberculosis (TB), by calling for…

Aidspan Publishes New Issue Of ‘Global Fund Observer’

Aidspan: Global Fund Observer Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 352 of the ‘Global Fund Observer.’ The newsletter includes pieces…

New WHO recommendations to accelerate progress on TB

20 March 2019: The World Health Organization (WHO) has issued new guidance to improve treatment of multidrug-resistant TB (MDR-TB). WHO is recommending shifting to fully oral regimens to treat people with…

WHO/Europe: New expert group on DR-TB to support more and better national research for treatment of resistant forms of TB

WHO has facilitated the creation of a new expert group on drug-resistant tuberculosis (DR-TB) to support Member States in improving their research on treatment. The areas of focus of the…

ECDC-WHO report: TB surveillance and monitoring in Europe 2019

Every hour 30 people are diagnosed with TB in the European Region. It’s time to make TB a disease of the past The latest ECDC-WHO report Tuberculosis surveillance and monitoring…

TAG statement on FDA priority review of pretomanid

Statement from Treatment Action Group on FDA priority peview of TB Alliance’s new anti-TB drug pretomanid. March 11, 2019 – Treatment Action Group (TAG) welcomes the exciting news of a…

TB CAB statement on safety of using bedaquiline and delamanid together

Global TB CAB welcomes confirmation of safety of using bedaquiline and delamanid together, urges uptake. March 12, 2019 – The Global TB Community Advisory Board (TB CAB) welcomes the important…

1 5 6 7 8 9 58